ATS 2018 International Conference - Mobile

John D. Mendlein

PhD

aTyr Pharma

Session(s)

Pre-Clinical Characterization of iMod.Fc, an Immune-Modulatory Therapeutic with Potentiall...
Sunday, May 20 9:15 AM - 11:15 AM